227 related articles for article (PubMed ID: 27913307)
1. Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery.
GuhaSarkar S; More P; Banerjee R
J Control Release; 2017 Jan; 245():147-156. PubMed ID: 27913307
[TBL] [Abstract][Full Text] [Related]
2. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
3. Synergistic locoregional chemoradiotherapy using a composite liposome-in-gel system as an injectable drug depot.
GuhaSarkar S; Pathak K; Sudhalkar N; More P; Goda JS; Gota V; Banerjee R
Int J Nanomedicine; 2016; 11():6435-6448. PubMed ID: 27942215
[TBL] [Abstract][Full Text] [Related]
4. Bladder tissue pharmacokinetics of intravesical taxol.
Song D; Wientjes MG; Au JL
Cancer Chemother Pharmacol; 1997; 40(4):285-92. PubMed ID: 9225946
[TBL] [Abstract][Full Text] [Related]
5. Bioadhesive drug delivery system using glyceryl monooleate for the intravesical administration of paclitaxel.
Lee SJ; Kim SW; Chung H; Park YT; Choi YW; Cho YH; Yoon MS
Chemotherapy; 2005 Oct; 51(6):311-8. PubMed ID: 16224181
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
Lu Z; Yeh TK; Tsai M; Au JL; Wientjes MG
Clin Cancer Res; 2004 Nov; 10(22):7677-84. PubMed ID: 15570001
[TBL] [Abstract][Full Text] [Related]
7. HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer.
Rosato A; Banzato A; De Luca G; Renier D; Bettella F; Pagano C; Esposito G; Zanovello P; Bassi P
Urol Oncol; 2006; 24(3):207-15. PubMed ID: 16678050
[TBL] [Abstract][Full Text] [Related]
8. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment.
Knemeyer I; Wientjes MG; Au JL
Cancer Chemother Pharmacol; 1999; 44(3):241-8. PubMed ID: 10453726
[TBL] [Abstract][Full Text] [Related]
9. Sustained intravesical drug delivery using thermosensitive hydrogel.
Tyagi P; Li Z; Chancellor M; De Groat WC; Yoshimura N; Huang L
Pharm Res; 2004 May; 21(5):832-7. PubMed ID: 15180342
[TBL] [Abstract][Full Text] [Related]
10. Bladder uptake of liposomes after intravesical administration occurs by endocytosis.
Rajaganapathy BR; Chancellor MB; Nirmal J; Dang L; Tyagi P
PLoS One; 2015; 10(3):e0122766. PubMed ID: 25811468
[TBL] [Abstract][Full Text] [Related]
11. The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm.
Tringali G; Lisi L; Bettella F; Renier D; Di Stasi SM; Navarra P
Pharmacol Res; 2008; 58(5-6):340-3. PubMed ID: 18848989
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive maleimide-functionalised liposomes for drug delivery to urinary bladder.
Kaldybekov DB; Tonglairoum P; Opanasopit P; Khutoryanskiy VV
Eur J Pharm Sci; 2018 Jan; 111():83-90. PubMed ID: 28958893
[TBL] [Abstract][Full Text] [Related]
13. In situ floating hydrogel for intravesical delivery of adriamycin without blocking urinary tract.
Lin T; Wu J; Zhao X; Lian H; Yuan A; Tang X; Zhao S; Guo H; Hu Y
J Pharm Sci; 2014 Mar; 103(3):927-36. PubMed ID: 24449076
[TBL] [Abstract][Full Text] [Related]
14. In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder.
Huygens A; Kamuhabwa AR; van Cleynenbreugel B; van Poppel H; Roskams T; de Witte PA
BJU Int; 2005 Feb; 95(3):436-41. PubMed ID: 15679810
[TBL] [Abstract][Full Text] [Related]
15. Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction.
Janicki JJ; Chancellor MB; Kaufman J; Gruber MA; Chancellor DD
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999210
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
Mugabe C; Hadaschik BA; Kainthan RK; Brooks DE; So AI; Gleave ME; Burt HM
BJU Int; 2009 Apr; 103(7):978-86. PubMed ID: 19007363
[TBL] [Abstract][Full Text] [Related]
17. Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.
Yoon HY; Chang IH; Goo YT; Kim CH; Kang TH; Kim SY; Lee SJ; Song SH; Whang YM; Choi YW
Int J Nanomedicine; 2019; 14():6249-6268. PubMed ID: 31496684
[TBL] [Abstract][Full Text] [Related]
18. Thermosensitive Hydrogel System With Paclitaxel Liposomes Used in Localized Drug Delivery System for In Situ Treatment of Tumor: Better Antitumor Efficacy and Lower Toxicity.
Mao Y; Li X; Chen G; Wang S
J Pharm Sci; 2016 Jan; 105(1):194-204. PubMed ID: 26580704
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer.
Le Visage C; Rioux-Leclercq N; Haller M; Breton P; Malavaud B; Leong K
J Urol; 2004 Mar; 171(3):1324-9. PubMed ID: 14767342
[TBL] [Abstract][Full Text] [Related]
20. Bladder wall penetration of intravesical mitomycin C in dogs.
Wientjes MG; Dalton JT; Badalament RA; Drago JR; Au JL
Cancer Res; 1991 Aug; 51(16):4347-54. PubMed ID: 1907883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
